Sohanya Cheng

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, Newton, MA
Signature
/s/Nancy Smith as Attorney-in-Fact for Sohanya Cheng
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sohanya Cheng:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP & Chief Commercial Officer Common 394K $472K $1.20 Mar 1, 2024 Direct
Karyopharm Therapeutics Inc. EVP & Chief Commercial Officer Common Stock 404K $292K $0.72 Sep 4, 2024 Direct

Insider Reports Filed by Sohanya Cheng

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. Sep 4, 2024 1 -$3.87K 4 Sep 5, 2024 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Feb 29, 2024 2 -$31.7K 4 Mar 4, 2024 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2024 1 $0 4 Feb 29, 2024 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Jan 24, 2024 1 $0 4 Jan 25, 2024 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Sep 1, 2023 1 -$9.87K 4 Sep 5, 2023 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Jun 8, 2023 1 -$4.32K 4 Jun 12, 2023 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2023 2 -$34K 4 Mar 2, 2023 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Aug 31, 2022 2 $0 4 Sep 1, 2022 EVP & Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Jun 13, 2022 2 -$8.07K 4 Jun 14, 2022 Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2022 2 $0 4 Mar 2, 2022 Chief Commercial Officer
KPTI Karyopharm Therapeutics Inc. Jun 30, 2021 2 $0 4 Jul 1, 2021 SVP Sales & Commercial Ops
KPTI Karyopharm Therapeutics Inc. Jun 7, 2021 0 $0 3 Jun 11, 2021 SVP Sales & Commercial Ops